The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNetscientific Share News (NSCI)

Share Price Information for Netscientific (NSCI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 64.50
Bid: 63.00
Ask: 66.00
Change: 1.00 (1.57%)
Spread: 3.00 (4.762%)
Open: 63.00
High: 66.50
Low: 61.50
Prev. Close: 63.50
NSCI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Goodbody Health wins deal; Tekcapital secures funds

Mon, 03rd Oct 2022 19:52

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

Pensana PLC - London-based rare earth metal miner - Signs a memorandum of understanding for the offtake of 25% of annual production to supply raw materials for the production of magnet materials. These are needed to support the rising demand for electric vehicles and offshore wind. Does not disclose financial details of the agreement.

"This agreement represents a significant step forward in our goal of providing an independent and sustainable supply of rare earth magnets for the electric vehicle and offshore wind industries. By having a significant partner across the globe, we now have further validation from the industry that Pensana's project is an essential element in the growing value chain for these critical minerals," Chair Paul Atherley comments.

----------

Spectra Systems Corp - Rhode Island, US-based authentication technology provider - Executes an amendment to a materials procurement contract to increase the price of specified materials supplied by approximately 21% relative to the current price. The contract is with an unnamed, long-standing central bank customer. The price increase will begin with the next order. The amendment is part of its efforts to mitigate supply chain issues. Says that it generated revenue of roughly USD5.9 million from sales of the specified materials under the earlier procurement contract.

----------

Goodbody Health Ltd - Vancouver-based diagnostics firm - Signs a distribution agreement with Tasso Inc. Expects to be rolling the devices out through its growing network of pharmacies in the UK later this year. "To supplement our in-clinic services, we have also expanded our range of 'at home' test kits offered on stands supplied though a range of outlets. We are pleased to have achieved the placement of our first 100 stands offering options for those who prefer to test in the comfort of their own home," the company states.

----------

Vulcan Industries PLC - London-based engineering services firm - Says there have been delays in finalising the audit of its annual report for the year which ended March 31. The delays have occurred as a result of the recent disposals of IVI Metallics Limited and Orca Doors Ltd. Expects to announce its audited financial statements early in October. AQSE has suspended trading in its shares at 0700 GMT on Thursday.

----------

PYX Resources Ltd - Sydney-based zircon producer - Secures a GBP20 million investment from GGY Global Yield LLC SCS. The proceeds from this capital investment will further the its effort to upgrade its mining operations and increase its production volumes.

----------

CML Microsystems PLC - Essex, England-based semiconductor developer - Launches a share buyback programme for up to GBP1.0 million. Decides to launch the programme to return funds to its shareholders. Has shareholder authority to repurchase 2.4 million shares of 5 pence each.

----------

Tekcapital PLC - London-based intellectual property investor - Says Innovative Eyewear Inc has licensed its brand Nautica for "smart eyewear." Expects the Nautica smart eyewear collection to launch for holiday 2022 "or soon thereafter."

----------

NetScientific PLC - London-based life sciences and sustainability technology investment firm - Completes the end-of-phase 2 meeting with the US Food & Drug Administration for PDS0101 in combination with Merck's anti-PD-1 therapy, Keytruda. It is for the treatment of unresectable, recurrent and metastatic human papillomavirus 16-positive head and neck squamous cell carcinoma.

----------

Rainbow Rare Earths Ltd - a Guernsey-based mining company focused on South Africa and Burundi - Says the preliminary economic assessment for its Phalaborwa rare earth project in South Africa confirms robust economics. Identifies total production of 26,208 tonnes of separated magnet rare earth oxides with a weighted average sales value of USD137.92 per kilogrammes, generating USD3.6 billion of revenue over 14.2 years. The PEA was conducted by METC Engineering.

----------

Ince Group PLC - London-based law and professional services firm - Agrees conditional heads of terms for the sale of Ince Gibraltar Ltd and Ince Consultancy Gibraltar Ltd, its two subsidiaries in Gibraltar. Agrees to sell Ince Gibraltar to Peter Howitt, a director of Ince Gibraltar, and Heather Adamson, an employee, for GBP700,000 in cashless approximately GBP210,000 in respect of certain costs.

----------

By Abby Amoakuh; abbyamoakuh@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
13 May 2024 18:55

EARNINGS AND TRADING: itim loss narrows; Vela trims EnSilica stake

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
10 May 2024 13:19

IN BRIEF: NetScientific says PDS Biotech's Versamune meets endpoints

NetScientific PLC - London-based deep tech and life sciences venture capital investor - Says its portfolio company, PDS Biotechnology Corp's Versamune meets endpoints in a phase three trial for patients with HPV. NetScientific holds a 3.5% shareholding in PDS. Versamune is a T cell-activating platform that effectively stimulates a precise immune system response to a cancer-specific protein.

Read more
15 Apr 2024 11:06

NetScientific investee secures funding to develop product range

(Alliance News) - NetScientific PLC on Monday said its portfolio company ProAxsis Ltd secured GBP1.8 million in investment.

Read more
27 Mar 2024 18:47

TRADING UPDATES: Empire Metals targets key milestones in Australia

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
13 Mar 2024 17:04

NetScientific "significantly" advances strategic goals

(Alliance News) - NetScientific PLC on Wednesday released a portfolio and strategy update.

Read more
23 Jan 2024 18:39

TRADING UPDATES: Esken's Southend Airport faces further allegations

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
1 Dec 2023 11:59

IN BRIEF: NetScientific investee DeepTech Recycling bags GBP1 million

NetScientific PLC - technology and life sciences investor - Portfolio company DeepTech Recycling Ltd closes GBP1 million fundraising. DeepTech, in which NetScientific holds a 30% stake, is a company focused on chemical recycling of plastic waste. Last December, it bought the assets of Recycling Technologies Ltd out of administration. The fundraise is carried out via an advance share subscription agreement and is the first closing of a target investment programme of around GBP3 million, with further investment anticipated within the next six months.

Read more
9 Nov 2023 19:41

IN BRIEF: NetScientific's portfolio company updates on cancer trial

NetScientific PLC - London-based deep tech and life sciences-focused venture capital investor -

Read more
6 Nov 2023 12:00

IN BRIEF: NetScientific says Ventive on fire with new investment

NetScientific PLC - London-based deep tech and life sciences-focused venture capital investor - Says portfolio company Ventive, a London-based designer and manufacturer of heating and ventillation solutions, has successfuly closed a new investment of around GBP900,000. Funding included GBP316,000 from existing shareholders and the conversion of two existing convertible loans valued at about GBP600,000. Investment is part of Ventive's proposed GBP1 million to GBP1.5 million programme, with further investments expected by April 30. NetScientific now holds an 11% total equity stake in Ventive, with a post-investment fair value of GBP893,000 - up from GBP52,000 at December 31.

Read more
23 Oct 2023 21:10

NetScientific investee claims promising results in biomarker study

(Alliance News) - NetScientific PLC on Monday said its investee PDS Biotechnology Corp was "encouraged" by study data for its PDS0101 combined with Merck & Co Inc's drug Keytruda.

Read more
3 Oct 2023 17:12

IN BRIEF: NetScientific portfolio company updates on cancer trial

NetScientific PLC - London-based deep tech and life sciences-focused venture capital investment company - Reports that its portfolio company, PDS Biotechnology Corp, has announced updated interim data from the Versatile-002 phase two clinical trial evaluating PDS0101 in combination with Merck & Co Inc's Keytruda in patients with unresectable, recurrent, or metastatic HPV16-positive head and neck squamous cell carcinoma.

Read more
28 Sep 2023 14:24

EARNINGS: Dar Global profit multiplies, Hemogenyx loss widens

(Alliance News) - The following is a round-up of earnings updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
13 Sep 2023 21:32

NetScientific's Q-Bot completes GBP3.5 million investment programme

(Alliance News) - NetScientific PLC on Wednesday said that its portfolio company, Q-Bot, has successfully closed a GBP3.5 million investment programme.

Read more
14 Aug 2023 19:49

IN BRIEF: NetScientific's PDS suffers wider loss as R&D costs mount

NetScientific PLC - London-based investment firm focused on life science, sustainability and technology companies - Portfolio company PDS Biotechnology Corp reports results for the quarter to June 30. Net loss was USD11.5 million, widened from USD5.8 million the year before. Higher loss primarily due to costs incurred in connection with research and development programmes, which more than doubled to USD8.0 million from USD3.8 million. Loss per share of USD0.37 compared to USD0.20 before. Further, PDS reports the successful submission of final clinical protocol and supporting information to the US Food & Drug Administration to initiate phase 3 Versatile-003 trial in the fourth quarter. Adds biomarker data from Versatile-002 will be presented at the European Society for Medical Oncology Congress.

Read more
30 Jun 2023 14:07

TRADING UPDATES: Pendragon quarterly trading momentum maintained

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.